Question 1

Does Wolverine Asset Management own BRIDGEBIO PHARMA stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Wolverine Asset Management holds 115,868,000 shares of BRIDGEBIO PHARMA, worth $180.3M.

Question 2

How many shares of BRIDGEBIO PHARMA does Wolverine Asset Management own?

Accepted Answer

As of its Q3 2026 13F, Wolverine Asset Management holds 115,868,000 shares of BRIDGEBIO PHARMA.

Question 3

What is Wolverine Asset Management's BRIDGEBIO PHARMA position worth?

Accepted Answer

As of its Q3 2026 13F, Wolverine Asset Management's BRIDGEBIO PHARMA position is worth $180.3M.

Question 4

Is Wolverine Asset Management buying or selling BRIDGEBIO PHARMA?

Accepted Answer

In Q3 2026, Wolverine Asset Management increased its BRIDGEBIO PHARMA position by 39,330,000 shares (+51.4%).

Question 5

When did Wolverine Asset Management first buy BRIDGEBIO PHARMA?

Accepted Answer

Wolverine Asset Management first reported BRIDGEBIO PHARMA in its Q1 2021 13F and has listed it in 17 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Increased	115.9M	+51.4%	$180.3M	1.2%	—	67
2026-Q2	Decreased	76.5M	-6.7%	$136.3M	1.2%	—	0
2026-Q1	Increased	82M	+79.7%	$147.7M	1.4%	—	73
2025-Q4	Decreased	45.7M	-49.4%	$86.2M	0.7%	—	0
2025-Q3	Unchanged	90.2M	0.0%	$126.6M	0.9%	—	0
2025-Q2	Increased	90.2M	+50.9%	$112.8M	1.0%	—	66
2025-Q1	Increased	59.8M	+24.8%	$68.2M	0.8%	—	51
2024-Q4	Increased	47.9M	+81.7%	$50.2M	0.5%	—	64
2024-Q3	Increased	26.4M	+66.4%	$27.2M	0.3%	—	50

BRBRIDGEBIO PHARMA INC